AU2001213150A1 - Composition of metformin with succinic acid or salts thereof and method for treating diabetes - Google Patents

Composition of metformin with succinic acid or salts thereof and method for treating diabetes

Info

Publication number
AU2001213150A1
AU2001213150A1 AU2001213150A AU1315001A AU2001213150A1 AU 2001213150 A1 AU2001213150 A1 AU 2001213150A1 AU 2001213150 A AU2001213150 A AU 2001213150A AU 1315001 A AU1315001 A AU 1315001A AU 2001213150 A1 AU2001213150 A1 AU 2001213150A1
Authority
AU
Australia
Prior art keywords
metformin
salts
composition
succinic acid
treating diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001213150A
Inventor
Olga Evgenievna Kolesova
Valentin Georgievich Nenajdenko
Igor Anatolievich Pomytkin
Tatyana Jurievna Ukhanova
Pavel Vasilievich Verteletsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001213150A1 publication Critical patent/AU2001213150A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001213150A 2000-08-03 2000-08-03 Composition of metformin with succinic acid or salts thereof and method for treating diabetes Abandoned AU2001213150A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2000/000322 WO2002012177A1 (en) 2000-08-03 2000-08-03 Composition of metformin with succinic acid or salts thereof and method for treating diabetes

Publications (1)

Publication Number Publication Date
AU2001213150A1 true AU2001213150A1 (en) 2002-02-18

Family

ID=20129537

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001213150A Abandoned AU2001213150A1 (en) 2000-08-03 2000-08-03 Composition of metformin with succinic acid or salts thereof and method for treating diabetes

Country Status (2)

Country Link
AU (1) AU2001213150A1 (en)
WO (1) WO2002012177A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818906B1 (en) 2000-12-29 2004-04-02 Dospharma DRUG ASSOCIATION OF A BIGUANINE AND A CARRIER, FOR EXAMPLE OF METFORMIN AND ARGININE
KR101226669B1 (en) * 2007-09-21 2013-01-25 한올바이오파마주식회사 Ｎ,Ｎ－dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
JP2015523382A (en) * 2012-07-10 2015-08-13 テティス・ファーマシューティカルズ・エルエルシー The trisalt form of metformin
US9382187B2 (en) 2012-07-10 2016-07-05 Thetis Pharmaceuticals Llc Tri-salt form of metformin
WO2015171516A1 (en) 2014-05-05 2015-11-12 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
US10166246B2 (en) 2014-05-27 2019-01-01 City Of Hope TGR5 agonist complexes for treating diabetes and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2611500B1 (en) * 1987-03-06 1990-05-04 Lipha USE OF BIGUANIDE DERIVATIVES IN THE PREPARATION OF MEDICINES
JP4278863B2 (en) * 1997-12-08 2009-06-17 ブリストル−マイヤーズ スクイブ カンパニー Novel salt and method of metformin
AU736951C (en) * 1998-03-19 2003-02-20 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method

Also Published As

Publication number Publication date
WO2002012177A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
NO20006407L (en) Method and composition for inhibiting the growth of microorganisms including per-acetic acid and a non-oxidizing biocide
AU2000276362A1 (en) Composition for the treatment of diabetes
WO1999063976A3 (en) Liver-selective glucocorticoid antagonist for treating diabetes
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
EE200100653A (en) Indolylpiperidine Compounds, Method of Preparation, Composition and Use thereof
AU2003225196A1 (en) Hydroxycitric acid salt composition and method of making
AU2001274181A1 (en) Composition and method for biocide treatment of surfaces
HUP0103405A3 (en) Crystal modification of lipoic acid, process for their preparation and their use
AU2001213150A1 (en) Composition of metformin with succinic acid or salts thereof and method for treating diabetes
AU2001275085A1 (en) Methods, compounds and compositions for treating gout
AU2002213106A1 (en) A composition and method for preparing amino acid chelates free of interfering ions
AU2002233353A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
AU4937699A (en) Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing
AU5327800A (en) Methods for treating skin with 3-hydroxy benzoic acid and related compositions
AU6252699A (en) Composition and method for treating allergic diseases
WO2002098843A3 (en) Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU2002245510A1 (en) Method and composition for embalming
AU3996799A (en) Alpha amino acid composition and method for the treatment of skin
AU2420101A (en) Method and composition for the treatment of pain
AU2002305700A1 (en) Composition and method for treating cells
HUP0203676A3 (en) Pharmaceutical composition and method for treatment of diabetes
AU2002316940A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
AU7604100A (en) Composition and method for treating burns
AU6391199A (en) Composition and method for treating allergic diseases